Under the rules of the CADP, the athlete has the right to pursue a hearing to contest CCES’ assertion of a violation
(Ottawa, Ontario – May 6, 2016) – The Canadian Centre for Ethics in Sport (CCES) announced today that under the rules of the Canadian Anti-Doping Program (CADP), it has asserted an anti-doping rule violation against Jonathan Fortin, a Canadian Interuniversity Sport (CIS) athlete affiliated with Bishop’s University. The athlete’s urine sample, collected during out-of-competition doping control on March 9, 2016, revealed the presence of Methandienone, a prohibited anabolic agent.
Under the rules of the CADP, the athlete has the right to pursue a hearing to contest CCES’ assertion of a violation. His case remains open until he either waives this right or pursues a hearing. At this point, Mr. Fortin does not have an anti-doping rule violation.
Rule 14.3.1 of the CADP provides the CCES with the authority to publicly disclose the identity of an athlete against whom the CCES has asserted an anti-doping rule violation. The CCES has exercised this authority given Mr. Fortin is eligible for the Canadian Football League’s (CFL) draft on May 10, 2016.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.